McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM, authors. Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res. 2006;15:241–9. [PubMed]
Kakizaki M, Kuriyama S, Sone T, et al., authors. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer. 2008;99:1502–5. [PubMed Central][PubMed]
Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC, authors. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis. 2008;29:1244–8. [PubMed Central][PubMed]
Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW, authors. Sleep duration and endometrial cancer risk. Cancer Causes Control. 2012;23:547–53. [PubMed]
Luo J, Sands M, Wactawski-Wende J, Song Y, Margolis KL, authors. Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol. 2013;177:42–9. [PubMed Central][PubMed]
Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR, authors. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the busselton health study cohort. J Clin Sleep Med. 2014;10:355–62. [PubMed Central][PubMed]
Li Q, Zheng T, Holford TR, Boyle P, Zhang Y, Dai M, authors. Light at night and breast cancer risk: results from a population-based case-control study in Connecticut, USA. Cancer Causes Control. 2010;21:2281–5. [PubMed Central][PubMed]
Zhang X, Giovannucci EL, Wu K, et al., authors. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 2013;36:681–8. [PubMed Central][PubMed]
Meier-Ewert HK, Ridker PM, Rifai N, et al., authors. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43:678–83. [PubMed]
Noguti J, Andersen ML, Cirelli C, Ribeiro DA, authors. Oxidative stress, cancer, and sleep deprivation: is there a logical link in this association? Sleep Breath. 2013;17:905–10. [PubMed]
Irwin M, Mascovich A, Gillin JC, Willoughby R, Pike J, Smith TL, authors. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom Med. 1994;56:493–8. [PubMed]
Li S, Qian XH, Zhou W, et al., authors. Time-dependent inflammatory factor production and NFkappaB activation in a rodent model of intermittent hypoxia. Swiss Med Wkly. 2011;141:w13309[PubMed]
Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N, authors. Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol. 2012;35:231–6. [PubMed]
Mormont MC, Waterhouse J, Bleuzen P, et al., authors. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000;6:3038–45. [PubMed]
Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D, authors. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000. [PubMed]
Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D, authors. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology. 2004;29:1082–92. [PubMed]
Palesh OG, Collie K, Batiuchok D, et al., authors. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007;75:37–44. [PubMed Central][PubMed]
Sephton SE, Lush E, Dedert EA, et al., authors. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav Immun. 2013;30 Suppl:S163–70. [PubMed]
Palesh O, Aldridge-Gerry A, Zeitzer JM, et al., authors. Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep. 2014;37:837–42. [PubMed Central][PubMed]
Levi F, Dugue PA, Innominato P, et al., authors. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 2014;1–10.
Cohen L, Cole SW, Sood AK, et al., authors. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One. 2012;7:e42324. [PubMed Central][PubMed]
Sephton S, Spiegel D, authors. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 2003;17:321–8. [PubMed]
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61–109. [PubMed]
Curb JD, McTiernan A, Heckbert SR, et al., authors. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003;13:S122–8. [PubMed]
Levine DW, Kripke DF, Kaplan RM, et al., authors. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003;15:137–48. [PubMed]
Vogtmann E, Levitan EB, Hale L, et al., authors. Association between sleep and breast cancer incidence among postmenopausal women in the Women's Health Initiative. Sleep. 2013;36:1437–44. [PubMed Central][PubMed]
Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB, authors. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013;108:213–21. [PubMed Central][PubMed]
Therneau TM, Grambsch PM, authors. Modeling survival data: extending the Cox model. New York, NY: Springer, 2000.
Groenwold RH, Donders AR, Roes KC, Harrell FE Jr, Moons KG, authors. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175:210–7. [PubMed]
White IR, Royston P, Wood AM, authors. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–99. [PubMed]
Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES, authors. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005;41:2023–32. [PubMed]
Kamdar BB, Tergas AI, Mateen FJ, Bhayani NH, Oh J, authors. Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138:291–301. [PubMed]
International Agency for Research on Cancer, World Health Organization Painting, firefighting, and shiftwork. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2007;98.
Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S, authors. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166:1756–62. [PubMed]
Irwin MR, Wang M, Ribeiro D, et al., authors. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008;64:538–40. [PubMed Central][PubMed]
Motivala S, Irwin MR, authors. Sleep and immunity: cytokine pathways linking sleep and health outcomes. Curr Dir Psychol Sci. 2007;16:21–5.
Htoo AK, Greenberg H, Tongia S, et al., authors. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath. 2006;10:43–50. [PubMed]
Yamauchi M, Tamaki S, Tomoda K, et al., authors. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath. 2006;10:189–93. [PubMed]
Balkwill F, Mantovani A, authors. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45. [PubMed]
Hakim F, Wang Y, Zhang SX, et al., authors. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res. 2014;74:1329–37. [PubMed Central][PubMed]
Maragno-Correa JM, Patti CL, Zanin KA, et al., authors. Sleep deprivation increases mortality in female mice bearing Ehrlich ascitic tumor. Neuroimmunomodulation. 2013;20:134–40. [PubMed]
Filipski E, King VM, Li X, et al., authors. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 2002;94:690–7. [PubMed]
Filipski E, Delaunay F, King VM, et al., authors. Effects of chronic jet lag on tumor progression in mice. Cancer Res. 2004;64:7879–85. [PubMed]
Almendros I, Montserrat JM, Torres M, et al., authors. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respir Physiol Neurobiol. 2013;186:303–7. [PubMed]
Almendros I, Montserrat JM, Ramirez J, et al., authors. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur J Respir J. 2012;39:215–7.
Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ, authors. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19:838–45. [PubMed Central][PubMed]
Lockley SW, Skene DJ, Arendt J, authors. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res. 1999;8:175–83. [PubMed]
Hauri PJ, Wisbey J, authors. Wrist actigraphy in insomnia. Sleep. 1992;15:293–301. [PubMed]
Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH, authors. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol. 2003;87:1–25. [PubMed]
Teran-Perez G, Arana-Lechuga Y, Esqueda-Leon E, Santana-Miranda R, Rojas-Zamorano JA, Velazquez Moctezuma J, authors. Steroid hormones and sleep regulation. Mini Rev Medicinal Chem. 2012;12:1040–8.
Stavaras C, Pastaka C, Papala M, et al., authors. Sexual function in pre- and post-menopausal women with obstructive sleep apnea syndrome. Int J Impotence Res. 2012;24:228–33.
Sowers MF, Zheng H, Kravitz HM, et al., authors. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index. Sleep. 2008;31:1339–49. [PubMed Central][PubMed]